Clinical trials of agents that reverse multidrug resistance. A literature review
- 15 December 1993
- Vol. 72 (12), 3553-3563
- https://doi.org/10.1002/1097-0142(19931215)72:12<3553::aid-cncr2820721203>3.0.co;2-b
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Various Methods of Analysis of mdr-1/P-Glycoprotein in Human Colon Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1992
- Monitoring the chemosensitizing effects of toremifene with flow cytometry in estrogen receptor negative multidrug resistant human breast cancer cellsBreast Cancer Research and Treatment, 1992
- Adequate tumour quinidine levels for multidrug resistance modulation can be achieved in vivoEuropean Journal of Cancer, 1992
- Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin AEuropean Journal of Cancer and Clinical Oncology, 1991
- An ethical look at intensive care for patients with malignanciesEuropean Journal of Cancer and Clinical Oncology, 1991
- Muscle metabolism and red cell ATP/ADP concentration during bicycle ergometer in patients with AMPD-deficiencyJournal of Molecular Medicine, 1991
- Unknotting the Complexities of Multidrug Resistance: The Involvement of DNA Topoisomerases in Drug Action and ResistanceJNCI Journal of the National Cancer Institute, 1989
- Enhancement of cytogenetic and cytotoxic effects on multidrug-resistant (MDR) cells by a calcium antagonist (verapamil)Mutation Research Letters, 1989
- The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humansAmerican Heart Journal, 1985
- Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of Doxorubicin (Adriamycin) in resistant P388 mouse leukemia cellsEuropean Journal of Cancer and Clinical Oncology, 1984